Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Epstein-Barr Virus Infections × toripalimab × 1 year × Clear all

Sponsor

Conditions

Triple Negative Breast Neoplasms 12 Nasopharyngeal Carcinoma 11 Carcinoma, Non-Small-Cell Lung 8 Breast Neoplasms 8 Esophageal Squamous Cell Carcinoma 7 Squamous Cell Carcinoma of Head and Neck 6 Neoplasms 6 Colorectal Neoplasms 6 Carcinoma, Renal Cell 5 Advanced Solid Tumor 5 Uterine Cervical Neoplasms 4 Recurrence 4 Small Cell Lung Carcinoma 3 Neoplasm Metastasis 3 Liver Neoplasms 3 Head and Neck Neoplasms 3 Carcinoma, Transitional Cell 3 Carcinoma, Hepatocellular 3 Stomach Neoplasms 2 Solid Tumor 2 Pancreatic Neoplasms 2 Oropharyngeal Neoplasms 2 NSCLC 2 Esophageal Neoplasms 2 Carcinoma, Squamous Cell 2 Urinary Bladder Neoplasms 1 Turcot syndrome 1 Stage IB-IIIB NSCLC 1 Solid Tumor, Adult 1 Solid Cancer 1

Interventions

Valganciclovir 3 Cisplatin 3 Vincristine 2 Rituximab 2 Radiotherapy, Intensity-Modulated 2 Prednisone 2 Matrix-M 2 Gemcitabine 2 Etoposide 2 Doxorubicin 2 Cyclophosphamide 2 pomalidomide 1 dehydroftorafur 1 brincidofovir 1 Watchful Waiting 1 Valacyclovir 1 Tomography, X-Ray Computed 1 Tenofovir 1 Tegafur 1 Taxes 1 Platinum 1 Phantoms, Imaging 1 Paclitaxel 1 Nivolumab 1 N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide 1 Mitomycin 1 Magnetic Resonance Spectroscopy 1 Lenalidomide 1 Interferons 1 Fluorouracil 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡